IMCEPSEO Trademark

Trademark Overview


On Friday, May 13, 2022, a trademark application was filed for IMCEPSEO with the United States Patent and Trademark Office. The USPTO has given the IMCEPSEO trademark a serial number of 97408975. The federal status of this trademark filing is REGISTERED as of Tuesday, April 9, 2024. This trademark is owned by AstraZeneca AB. The IMCEPSEO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines
imcepseo

General Information


Serial Number97408975
Word MarkIMCEPSEO
Filing DateFriday, May 13, 2022
Status700 - REGISTERED
Status DateTuesday, April 9, 2024
Registration Number7350179
Registration DateTuesday, April 9, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 11, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events


Event DateEvent Description
Tuesday, April 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, March 1, 20241(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, January 8, 2024NOTICE OF ALLOWANCE CANCELLED
Friday, March 1, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 8, 2024TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, September 5, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 21, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 7, 2023ELECTRONIC RECORD REVIEW COMPLETE
Friday, June 2, 2023ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, May 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 23, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 23, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 10, 2023NON-FINAL ACTION E-MAILED
Friday, March 10, 2023NON-FINAL ACTION WRITTEN
Friday, March 3, 2023ASSIGNED TO EXAMINER
Wednesday, May 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 17, 2022NEW APPLICATION ENTERED